Overview and Scope
Cell surface marker detection refers to a process of classifying cells based on their markers. Cell surface markers are proteins expressed on the surface of cells or carbohydrates linked to the cell membrane that can be used to identify specific cell types. It is used to categorize cells based on their markers. This information is similar to fingerprints which are unique to each cell type and may be identified based on the kinds of markers present on the membrane.
Sizing and Forecast
The cell surface marker detection market size has grown strongly in recent years. It will grow from $5.52 billion in 2023 to $6.06 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to expansion in biomedical research, evolution of high-content screening, increased chronic disease prevalence, shift towards immunotherapy..
The cell surface marker detection market size is expected to see rapid growth in the next few years. It will grow to $8.95 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to market expansion in emerging economies, expanding biopharmaceutical sector, adoption of single-cell analysis, rise in chronic and infectious diseases, increasing funding for life sciences research.. Major trends in the forecast period include advancements in biotechnology, product innovations , technological innovations in flow cytometry, rising prevalence of chronic diseases..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-surface-marker-detection-global-market-report
Segmentation & Regional Insights
The cell surface marker detection market covered in this report is segmented –
1) By Product: Flow Cytometry, Hematology Analyzers, Reagents and Kits
2) By Application: Disease Diagnosis, Diseases Identification, Research for Drug Discovery, Cytological Academic Research
3) By End-Users: Pharmaceutical and Biotechnology Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes, Other End Users
North America was the largest region in the cell surface marker detection market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell surface marker detection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8619&type=smp
Major Driver Impacting Market Growth
The increasing number of oncology diseases is expected to propel the growth of the cell surface marker detection market going forward. Cancer is a condition in which some cells develop uncontrollably and spread to other body parts. The adoption of western lifestyles, poor dietary habits, frequent non-vegetarian diets, chemical pollution, and a lack of exercise have all contributed to the rise in cancer cases worldwide. Cell surface marker detection support cancer cell with the point-of-care prediction of patient response to several cancer drugs, thus increasing the demand. For instance, in October 2022, Macmillan Cancer Support, the largest UK-based health care charity organization, estimated that there were 3 million people having cancer in 2020, and it is estimated that it will rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising incidence of oncology diseases drives the growth of the cell surface marker detection market.
Key Industry Players
Major companies operating in the cell surface marker detection market report are Thermo Fisher Scientific Inc., Beckman Coulter Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Sartorius, Becton Dickinson and Company, BD Biosciences, Grifols SA, Applied Microarrays Inc., R&D Systems, Agilent Inc., Sigma-Aldrich, Qiagen NV, Sysmex Corporation, Nihon Kohden Corporation, Abnova Corporation, Diasorin SpA, Janssen Diagnostics, Biorad Laboratories, Abcam plc, GenScript Biotech, BioLegend, Cell Signaling Technology Inc., Merck KGaA, Bio-Techne Corporation, Affymetrix, Danaher Corporation, Zymo Research Corporation, Miltenyi Biotec
The cell surface marker detection market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
